Evidence map›Paper›PMID 38646281›Full record

ArticleCureus2024

A Rare Case of Dual Metachronous Primary Malignancies, Chronic Myeloid Leukemia, and Tongue Carcinoma in a Patient With Long-Standing Systemic Lupus Erythematosus: A Case Report and Review of Literature.

Sitaraman BalajiSubramanian, Thuraya Al-Hajri, Namrata Satyapal, Mahdiya Al-Bulushi, Salma Mohammed Al Sheibani, Faisal Khamis Mubarak Al Kalbani, Maimuna Al-Saadi, Muhanna Nasser Al Musalhi, Humaid A Al Wahshi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sitaraman BalajiSubramanianDepartment of Radiation Oncology, The Royal Hospital, Muscat, OMN.
Thuraya Al-HajriDepartment of Radiation Oncology, The Royal Hospital, Muscat, OMN.
Namrata SatyapalDepartment of Radiation Oncology, The Royal Hospital, Muscat, OMN.
Mahdiya Al-BulushiDepartment of Hematology, The Royal Hospital, Muscat, OMN.
Salma Mohammed Al SheibaniDepartment of Otolaryngology - Head and Neck Surgery, An Nahdha Hospital, Muscat, OMN.
Faisal Khamis Mubarak Al KalbaniDepartment of Otolaryngology - Head and Neck Surgery, An Nahdha Hospital, Muscat, OMN.
Maimuna Al-SaadiDepartment of Pathology, Khoula Hospital, Muscat, OMN.
Muhanna Nasser Al MusalhiDepartment of Hematology, The Royal Hospital, Muscat, OMN.
Humaid A Al WahshiDepartment of Medicine, The Royal Hospital, Muscat, OMN.
Al Nahdha Hospital · OMKhoula Hospital · OMRoyal Hospital · OM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patients with long-standing autoimmune diseases like systemic lupus erythematosus (SLE) are at a higher risk of developing hematological malignancies. However, chronic myeloid leukemia (CML) has rarely been reported in patients with SLE. Advancements in medical diagnostics and treatment have led to the life expectancy of SLE and CML patients moving closer to that of the general population, and it is not uncommon to encounter more than one malignancy in a cancer survivor. Although squamous cell carcinoma (SCC) of the skin has been reported in CML patients, mucosal SCC of the head and neck has rarely only been reported in CML survivors. The objective of this case report is to share our experience in treating a patient with dual metachronous primary malignancies, CML, and tongue carcinoma, along with long-standing SLE, managed by a multidisciplinary team.

Indexed as

autoimmunechronic myeloid leukemiadasatinibhead and neck cancerhematological malignanciesradiotherapysystemic lupus erythematosustongue carcinomavmat

Identifiers

PMID38646281
PMCPMC11032168
OpenAlexW4393032583

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.